V

Verona Pharma plc

D
VRNA
USD
-0.2
(-0.5214%)
Market Closed
21,227.00
Volume
-1.60592
EPS
-
Div Yield
-23.850000
P/E
3,099,933,552.96
Market Cap
Today
1.5164%
1 Week
12.434%
1 Month
19.027%
6 Months
158.012%
12 Months
160.478%
Year To Date
92.145%
All Time
0%

Title:
Verona Pharma plc

Sector:
Healthcare
Industry:
Biotechnology
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
Do you need help or have a question?